NDC 70518-0559

Abacavir

Abacavir

Abacavir is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Remedyrepack Inc.. The primary component is Abacavir Sulfat.

Product ID70518-0559_50ebc53e-1458-34d2-e054-00144ff88e88
NDC70518-0559
Product TypeHuman Prescription Drug
Proprietary NameAbacavir
Generic NameAbacavir
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2017-05-30
Marketing CategoryANDA / ANDA
Application NumberANDA077844
Labeler NameREMEDYREPACK INC.
Substance NameABACAVIR SULFAT
Active Ingredient Strength300 mg/1
Pharm ClassesHuman Immunodef
NDC Exclude FlagE
Listing Certified Through2018-12-31

Packaging

NDC 70518-0559-0

30 TABLET, FILM COATED in 1 BLISTER PACK (70518-0559-0)
Marketing Start Date2017-05-30
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 70518-0559-0 [70518055900]

Abacavir TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA077844
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-05-30
Marketing End Date2020-04-07

Drug Details

Pharmacological Class

  • Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
  • Nucleoside Analog [EXT]
  • Nucleoside Reverse Transcriptase Inhibitors [MoA]

NDC Crossover Matching brand name "Abacavir" or generic name "Abacavir"

NDCBrand NameGeneric Name
0121-0897AbacavirAbacavir
0904-6874AbacavirAbacavir
31722-557AbacavirAbacavir
31722-562AbacavirAbacavir
50268-049AbacavirAbacavir
64380-717AbacavirAbacavir
64980-405AbacavirAbacavir Sulfate
65862-073AbacavirAbacavir
65862-089AbacavirAbacavir Sulfate
68084-021AbacavirAbacavir Sulfate
69097-514AbacavirAbacavir
70518-0559AbacavirAbacavir
70518-1274AbacavirAbacavir
72865-167AbacavirAbacavir

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.